Patricia M. Danzon : Citation Profile


Are you Patricia M. Danzon?

University of Pennsylvania

15

H index

20

i10 index

795

Citations

RESEARCH PRODUCTION:

42

Articles

14

Papers

3

Books

5

Chapters

EDITOR:

1

Books edited

RESEARCH ACTIVITY:

   36 years (1982 - 2018). See details.
   Cites by year: 22
   Journals where Patricia M. Danzon has often published
   Relations with other researchers
   Recent citing documents: 75.    Total self citations: 18 (2.21 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pda291
   Updated: 2019-07-14    RAS profile: 2018-12-14    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Towse, Adrian (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon.

Is cited by:

Brekke, Kurt (18)

Pammolli, Fabio (18)

Magazzini, Laura (13)

Straume, Odd Rune (13)

Costa-i-Font, Joan (13)

Riccaboni, Massimo (11)

Kyle, Margaret (11)

Jelovac, Izabela (11)

Jimenez-Martin, Sergi (11)

Cabrales, Antonio (9)

Pertile, Paolo (9)

Cites to:

Cockburn, Iain (7)

DiMasi, Joseph (7)

Dranove, David (6)

Valletti, Tommaso (6)

Szymanski, Stefan (6)

Newhouse, Joseph (4)

Henderson, Rebecca (4)

Salkever, David (4)

Kyle, Margaret (4)

Winter, Ralph (3)

Acemoglu, Daron (3)

Main data


Where Patricia M. Danzon has published?


Journals with more than one article published# docs
Health Economics5
Journal of Law and Economics5
Journal of Health Economics5
Journal of Policy Analysis and Management4
International Journal of the Economics of Business3
The Journal of Business2
The Journal of Legal Studies2
American Economic Review2
Managerial and Decision Economics2

Recent works citing Patricia M. Danzon (2018 and 2017)


YearTitle of citing document
2017Bargaining over Entry with a Compulsory License Deadline: Price Spillovers and Surplus Expansion. (2017). Saggi, Kamal ; Bond, Eric. In: American Economic Journal: Microeconomics. RePEc:aea:aejmic:v:9:y:2017:i:1:p:31-62.

Full description at Econpapers || Download paper

2017DOES TELEVISION ENTRY DECREASE THE NUMBER OF MOVIE THEATERS?. (2017). Gutierrez-Navratil, Fernanda ; Gil, Ricard. In: Economic Inquiry. RePEc:bla:ecinqu:v:55:y:2017:i:2:p:736-756.

Full description at Econpapers || Download paper

2017Squeezing the Last Drop Out of Your Suppliers: An Empirical Study of Market-Based Purchasing Policies for Generic Pharmaceuticals. (2017). Bergman, Mats A ; Rudholm, Niklas ; Granlund, David. In: Oxford Bulletin of Economics and Statistics. RePEc:bla:obuest:v:79:y:2017:i:6:p:969-996.

Full description at Econpapers || Download paper

2017Medical Malpractice: How Legal Liability Affects Medical Decisions. (2017). Grembi, Veronica ; Bertoli, Paola. In: CERGE-EI Working Papers. RePEc:cer:papers:wp600.

Full description at Econpapers || Download paper

2017Risk-sharing benefits and the capital structure of insurance companies. (2017). Degryse, Hans ; van Hulle, Cynthia ; Smedts, Kristien . In: CEPR Discussion Papers. RePEc:cpr:ceprdp:11838.

Full description at Econpapers || Download paper

2018On the Effect of Parallel Trade on Manufacturers and Retailers Profits in the Pharmaceutical Sector. (2018). Sæthre, Morten ; Dubois, Pierre. In: CEPR Discussion Papers. RePEc:cpr:ceprdp:12649.

Full description at Econpapers || Download paper

2018Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals. (2018). Kremer, Michael ; Snyder, Christopher. In: CEPR Discussion Papers. RePEc:cpr:ceprdp:12751.

Full description at Econpapers || Download paper

2017Survey of Energy Finance on the Corporate World. (2017). Althaqeb, Saud. In: International Journal of Energy Economics and Policy. RePEc:eco:journ2:2017-06-19.

Full description at Econpapers || Download paper

2017Cross-border mergers and acquisitions with heterogeneous firms: Technology vs. market motives. (2017). Lee, Dong Hyun . In: The North American Journal of Economics and Finance. RePEc:eee:ecofin:v:42:y:2017:i:c:p:20-37.

Full description at Econpapers || Download paper

2017Compulsory licensing of pharmaceuticals by the developing south. (2017). Senra, Rafael Pinho. In: Economics Letters. RePEc:eee:ecolet:v:161:y:2017:i:c:p:74-77.

Full description at Econpapers || Download paper

2017A real options game of alliance timing decisions in biopharmaceutical research and development. (2017). Morreale, Azzurra ; Roma, Paolo ; lo Nigro, Giovanna ; ROBBA, SERENA . In: European Journal of Operational Research. RePEc:eee:ejores:v:261:y:2017:i:3:p:1189-1202.

Full description at Econpapers || Download paper

2017Optimizing healthcare network design under reference pricing and parameter uncertainty. (2017). Denoyel, Victoire ; Thiele, Aurelie ; Alfandari, Laurent. In: European Journal of Operational Research. RePEc:eee:ejores:v:263:y:2017:i:3:p:996-1006.

Full description at Econpapers || Download paper

2018Non-cooperative dynamic games for general insurance markets. (2018). Boonen, Tim J ; Wu, Renchao ; Pantelous, Athanasios A. In: Insurance: Mathematics and Economics. RePEc:eee:insuma:v:78:y:2018:i:c:p:123-135.

Full description at Econpapers || Download paper

2017The structure of the global reinsurance market: An analysis of efficiency, scale, and scope. (2017). Biener, Christian ; Jia, Ruo ; Eling, Martin. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:77:y:2017:i:c:p:213-229.

Full description at Econpapers || Download paper

2019Effects of price cap regulation on the pharmaceutical supply chain. (2019). Wang, Xiaojun ; Yang, Huan ; Chen, XU. In: Journal of Business Research. RePEc:eee:jbrese:v:97:y:2019:i:c:p:281-290.

Full description at Econpapers || Download paper

2018Does it pay to get connected? An examination of bank alliance network and bond spread. (2018). TARAZI, Amine ; HASAN, IFTEKHAR ; Zhou, Mingming ; Meslier, Celine. In: Journal of Economics and Business. RePEc:eee:jebusi:v:95:y:2018:i:c:p:141-163.

Full description at Econpapers || Download paper

2018Price competition in pharmaceuticals – Evidence from 1303 Swedish markets. (2018). Granlund, David ; Bergman, Mats A. In: Journal of Health Economics. RePEc:eee:jhecon:v:61:y:2018:i:c:p:1-12.

Full description at Econpapers || Download paper

2017Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry. (2017). Siebert, Ralph ; Banerjee, Tannista. In: Research Policy. RePEc:eee:respol:v:46:y:2017:i:7:p:1255-1271.

Full description at Econpapers || Download paper

2018R&D subsidies & external collaborative breadth: Differential gains and the role of collaboration experience. (2018). Chapman, Gary ; Afcha, Sergio ; Lucena, Abel. In: Research Policy. RePEc:eee:respol:v:47:y:2018:i:3:p:623-636.

Full description at Econpapers || Download paper

2018Market size and innovation: The intermediary role of technology licensing. (2018). Hermosilla, Manuel ; Wu, Yufei. In: Research Policy. RePEc:eee:respol:v:47:y:2018:i:5:p:980-991.

Full description at Econpapers || Download paper

2019The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. (2019). Wouters, Olivier J ; Kanavos, Panos G ; Pillay, Anban ; Sandberg, Dale M. In: Social Science & Medicine. RePEc:eee:socmed:v:220:y:2019:i:c:p:362-370.

Full description at Econpapers || Download paper

2018What and how do SMEs gain by going international? A longitudinal investigation of financial and intellectual resource growth. (2018). Li, Lei ; Shi, Weilei ; Goerzen, Anthony. In: Journal of World Business. RePEc:eee:worbus:v:53:y:2018:i:6:p:817-834.

Full description at Econpapers || Download paper

2019The Effect of Diversification under Different Ownership Structures and Economic Conditions: Evidence from the Great Recession. (2019). Lin, Zhilu ; Liebenberg, Ivonne A. In: Journal of Risk and Financial Management. RePEc:gam:jjrfmx:v:12:y:2019:i:2:p:82-:d:230166.

Full description at Econpapers || Download paper

2019Non-Tariff Barriers and Bargaining in Generic Pharmaceuticals. (2019). Ganapati, Sharat ; Mckibbin, Rebecca . In: Working Papers. RePEc:geo:guwopa:gueconwpa~18-18-23.

Full description at Econpapers || Download paper

2019Lawyer Fee Arrangements and Litigation Outcomes: An Auction-Theoretic Perspective. (2019). Gabuthy, Yannick ; MORAND, Pierre-Henri . In: Working Papers. RePEc:hal:wpaper:hal-01973660.

Full description at Econpapers || Download paper

2017On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector.. (2017). Sæthre, Morten ; Dubois, Pierre ; Sathre, Morten. In: Discussion Paper Series in Economics. RePEc:hhs:nhheco:2018_003.

Full description at Econpapers || Download paper

2018Quality Regulation and Competition: Evidence from Pharmaceutical Markets. (2018). Sæthre, Morten ; Sathre, Morten ; Cuesta, Jose Ignacio ; Atal, Juan Pablo. In: Discussion Paper Series in Economics. RePEc:hhs:nhheco:2018_020.

Full description at Econpapers || Download paper

2017Price competition in pharmaceuticals – evidence from 1303 Swedish markets. (2017). Granlund, David ; Bergman, Mats A. In: Umeå Economic Studies. RePEc:hhs:umnees:0952.

Full description at Econpapers || Download paper

2017Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs. (2017). Wunnava, Phanindra ; Fossett, Sarah J. In: IZA Discussion Papers. RePEc:iza:izadps:dp10817.

Full description at Econpapers || Download paper

2018The Impact of Sickness Absenteeism on Productivity: New Evidence from Belgian Matched Panel Data. (2018). Rycx, Francois ; Grinza, Elena. In: IZA Discussion Papers. RePEc:iza:izadps:dp11543.

Full description at Econpapers || Download paper

2017The impact of firms’ adjustments on the indirect cost of illness. (2017). Jakubczyk, Michał ; Ko, Beata. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:17:y:2017:i:3:d:10.1007_s10754-017-9212-1.

Full description at Econpapers || Download paper

2019Attorney fees in repeated relationships. (2019). Robles, Jack ; Graham, Brad . In: Journal of Economics. RePEc:kap:jeczfn:v:127:y:2019:i:2:d:10.1007_s00712-018-0633-1.

Full description at Econpapers || Download paper

2018Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals. (2018). Kremer, Michael ; Snyder, Christopher M. In: Review of Industrial Organization. RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9621-4.

Full description at Econpapers || Download paper

2018Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity. (2018). Olson, Luke M ; Wendling, Brett W. In: Review of Industrial Organization. RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9627-y.

Full description at Econpapers || Download paper

2018The Impact of the Entry of Biosimilars: Evidence from Europe. (2018). Scott, Fiona M ; Stern, Scott. In: Review of Industrial Organization. RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9630-3.

Full description at Econpapers || Download paper

2017Have Pharmaceutical R&D Project Success Rates Decreased? A Critical Review and New Empirical Results. (2017). Backfisch, Martin. In: MAGKS Papers on Economics. RePEc:mar:magkse:201746.

Full description at Econpapers || Download paper

2018The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010. (2018). Backfisch, Martin. In: MAGKS Papers on Economics. RePEc:mar:magkse:201813.

Full description at Econpapers || Download paper

2018Quali driver nella selezione delle target in operazioni di M&A? Una verifica empirica nel mercato italiano. (2018). Fidanza, Barbara. In: Working Papers. RePEc:mcr:wpaper:wpaper00052.

Full description at Econpapers || Download paper

2019The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals. (2019). Kyle, Margaret K. In: NBER Chapters. RePEc:nbr:nberch:14260.

Full description at Econpapers || Download paper

2018The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries. (2018). Lichtenberg, Frank. In: NBER Working Papers. RePEc:nbr:nberwo:24536.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084.

Full description at Econpapers || Download paper

2018A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Towse, A ; Shaw, B ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:002015.

Full description at Econpapers || Download paper

2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C. (2018). Sampson, Christopher ; Neri, Margherita ; Garau, Martina ; Berdud, Mikel ; Towse, A ; O'Neill, P. In: Research Papers. RePEc:ohe:respap:002040.

Full description at Econpapers || Download paper

2019The Future of Global Health Procurement: Issues around Pricing Transparency. (2019). Berdud, M ; Towse, A ; Nemzoff, C ; Garrison, L ; Ferraro, J ; Dean, E ; Chalkidou, K. In: Research Papers. RePEc:ohe:respap:002150.

Full description at Econpapers || Download paper

2018Tort Reforms and the Gender Distribution of Physicians. (2018). Li, Hsueh-Hsiang ; Bernasek, Alexandra. In: Eastern Economic Journal. RePEc:pal:easeco:v:44:y:2018:i:3:d:10.1057_s41302-018-0107-8.

Full description at Econpapers || Download paper

2017One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry. (2017). Billette de Villemeur, Etienne ; Versaevel, Bruno. In: MPRA Paper. RePEc:pra:mprapa:76903.

Full description at Econpapers || Download paper

2018Efficient Liability in Expert Markets. (2018). Chen, Yongmin ; Zhang, Jin ; Li, Jianpei. In: MPRA Paper. RePEc:pra:mprapa:87317.

Full description at Econpapers || Download paper

2017Intangibles and the Market Value of Biopharmaceutical Startups. (2017). Radoniqi, Fatos ; Morales, Rosa. In: MPRA Paper. RePEc:pra:mprapa:88580.

Full description at Econpapers || Download paper

2017Insurance and Insurance Markets. (2017). Dionne, Georges ; Harrington, Scott . In: Working Papers. RePEc:ris:crcrmw:2017_002.

Full description at Econpapers || Download paper

2017Reinsurance Demand and Liquidity Creation. (2017). Dionne, Georges ; Desjardins, Denise. In: Working Papers. RePEc:ris:crcrmw:2017_003.

Full description at Econpapers || Download paper

2018Анализ проблем и возможностей использования референтного ценообразования органами государственной власти . (2018). Rovbel, R ; Р. Ровбель Л., . In: Управленческие науки // Management Science. RePEc:scn:mngsci:y:2018:i:2:p:44-51.

Full description at Econpapers || Download paper

2018АНДЕРРАЙТИНГОВЫЕ ЦИКЛЫ И КРИЗИСЫ // Underwriting Cycles and Crises. (2018). Manikowski, Piotr ; П. Маниковский, . In: Мир новой экономики // The world of new economy. RePEc:scn:wnewec:y:2016:i:4:p:76-81.

Full description at Econpapers || Download paper

2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

Full description at Econpapers || Download paper

2017The Medicaid Rebate: Changes in Oncology Drug Prices After the Affordable Care Act. (2017). Tehrani, Ali Bonakdar ; Carroll, Norman V. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:4:d:10.1007_s40258-017-0314-1.

Full description at Econpapers || Download paper

2017Pareto-improving income redistribution: expanding consumer access to the vaccines market. (2017). Garcia-del-Barrio, Pedro. In: Economics of Governance. RePEc:spr:ecogov:v:18:y:2017:i:3:d:10.1007_s10101-017-0190-z.

Full description at Econpapers || Download paper

2018Courts, scheduled damages, and medical malpractice insurance. (2018). Grembi, Veronica ; Bertoli, Paola. In: Empirical Economics. RePEc:spr:empeco:v:55:y:2018:i:2:d:10.1007_s00181-017-1279-5.

Full description at Econpapers || Download paper

2017Why trash don’t pass? pharmaceutical licensing and safety performance of drugs. (2017). Banerjee, Tannista ; Nayak, Arnab. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:1:d:10.1007_s10198-015-0758-x.

Full description at Econpapers || Download paper

2017Measuring the efficiency of large pharmaceutical companies: an industry analysis. (2017). Gascon, Fernando ; Fuente, David ; Ponte, Borja ; Lozano, Jesus . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:5:d:10.1007_s10198-016-0812-3.

Full description at Econpapers || Download paper

2017Valuing productivity loss due to absenteeism: firm-level evidence from a Canadian linked employer-employee survey. (2017). Woodcock, Simon ; Zhang, Wei ; Anis, Aslam H ; Sun, Huiying . In: Health Economics Review. RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-016-0138-y.

Full description at Econpapers || Download paper

2017Convergence and determinants of health expenditures in OECD countries. (2017). Nghiem, Hong Son ; Connelly, Luke Brian . In: Health Economics Review. RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-017-0164-4.

Full description at Econpapers || Download paper

2018Medical practice and malpractice litigation in an evolutionary context. (2018). Antoci, Angelo ; Russu, Paolo ; Maccioni, Alessandro Fiori. In: Journal of Evolutionary Economics. RePEc:spr:joevec:v:28:y:2018:i:4:d:10.1007_s00191-018-0578-0.

Full description at Econpapers || Download paper

2018The determinants of startup valuation in the venture capital context: a systematic review and avenues for future research. (2018). Kohn, Andreas. In: Management Review Quarterly. RePEc:spr:manrev:v:68:y:2018:i:1:d:10.1007_s11301-017-0131-5.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

2017FDI entry mode choice and ownership structure in Turkish market: A firm-level analysis. (2017). Polat, Burak ; Wang, Miao Grace. In: Cogent Economics & Finance. RePEc:taf:oaefxx:v:5:y:2017:i:1:p:1283762.

Full description at Econpapers || Download paper

2017Launch Decisions of Pharmaceutical Companies. (2017). Civan, Abdulkadir ; Maloney, Michael . In: Journal of Economics and Financial Analysis. RePEc:trp:01jefa:jefa0008.

Full description at Econpapers || Download paper

2018On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector. (2018). Sæthre, Morten ; Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:32393.

Full description at Econpapers || Download paper

2018The Impact of Sickness Absenteeism on Productivity: New Evidence from Belgian Matched Panel Data. (2018). Rycx, Francois ; Grinza, Elena. In: Working papers. RePEc:tur:wpapnw:051.

Full description at Econpapers || Download paper

2018Análisis Comparativo de Precios de Medicamentos en América Latina. (2018). Gonzalez, Aldo ; Alvarez, Roberto. In: Working Papers. RePEc:udc:wpaper:wp462.

Full description at Econpapers || Download paper

2019Public Interest or Regulatory Capture: Theory and Evidence from China’s Airfare Deregulation. (2019). Wan, Wei ; Long, Cheryl ; Li, Kai. In: Working Papers. RePEc:wyi:wpaper:002399.

Full description at Econpapers || Download paper

2017Medical Malpractice: How legal liability affects medical decisions. (2017). Grembi, Veronica ; Bertoli, Grembi P. In: Health, Econometrics and Data Group (HEDG) Working Papers. RePEc:yor:hectdg:17/14.

Full description at Econpapers || Download paper

2017Removing geo-blocking: What are the effects on innovation for vertically differentiated goods?. (2017). Hamelmann, Lisa ; Klein, Gordon J. In: CAWM Discussion Papers. RePEc:zbw:cawmdp:100.

Full description at Econpapers || Download paper

2019Parallel trade and reimbursement regulation. (2015). Birg, Laura. In: Center for European, Governance and Economic Development Research Discussion Papers. RePEc:zbw:cegedp:253.

Full description at Econpapers || Download paper

2019Product patents and access to innovative medicines in a post-trips-era. (2019). Dai, Rong ; Watal, Jayashree. In: WTO Staff Working Papers. RePEc:zbw:wtowps:ersd201905.

Full description at Econpapers || Download paper

Patricia M. Danzon has edited the books:


YearTitleTypeCited

Works by Patricia M. Danzon:


YearTitleTypeCited
1988The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review.
[Full Text][Citation analysis]
article2
1990The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review.
[Full Text][Citation analysis]
article5
1990THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME..(1990) In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
This paper has another version. Agregated cites: 5
paper
1991Liability for Medical Malpractice In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article42
2000Liability for medical malpractice.(2000) In: Handbook of Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 42
chapter
1994Health Care Reform In: Australian Economic Review.
[Full Text][Citation analysis]
article4
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article33
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 33
chapter
2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 33
paper
1994The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics.
[Full Text][Citation analysis]
article3
2008Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance.
[Full Text][Citation analysis]
article6
1997Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation.
[Full Text][Citation analysis]
article69
2000Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics.
[Full Text][Citation analysis]
article75
1982Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics.
[Full Text][Citation analysis]
article14
2002Welfare effects of supplementary insurance: a comment In: Journal of Health Economics.
[Full Text][Citation analysis]
article8
2005Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics.
[Full Text][Citation analysis]
article51
2003Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 51
paper
1985Liability and liability insurance for medical malpractice In: Journal of Health Economics.
[Full Text][Citation analysis]
article14
1984Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics.
[Full Text][Citation analysis]
article3
2012Regulation of the Biopharmaceutical Industry In: Chapters.
[Full Text][Citation analysis]
chapter0
1990Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
paper2
2002Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs.
[Full Text][Citation analysis]
paper0
2014Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters.
[Full Text][Citation analysis]
chapter1
1999The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters.
[Full Text][Citation analysis]
chapter2
2004Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers.
[Full Text][Citation analysis]
paper39
2007Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 39
article
2008Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper16
2011Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers.
[Full Text][Citation analysis]
paper6
2015Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 6
article
2011Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2011Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 1
article
2011Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper6
2012Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers.
[Full Text][Citation analysis]
paper12
2015Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12
article
2002Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers.
[Full Text][Citation analysis]
paper44
2003The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers.
[Full Text][Citation analysis]
paper54
2005The impact of price regulation on the launch delay of new drugs-evidence from twenty-five major markets in the 1990s.(2005) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 54
article
1997Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monographs.
[Full Text][Citation analysis]
book5
2000Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monographs.
[Full Text][Citation analysis]
book1
2002The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monographs.
[Full Text][Citation analysis]
book4
2011Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Papers.
[Full Text][Citation analysis]
paper1
1994Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy.
[Citation analysis]
article1
1990Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article3
1983Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics.
[Full Text][Citation analysis]
article40
2018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2015Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article0
1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article27
1993The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics.
[Full Text][Citation analysis]
article13
2002Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics.
[Full Text][Citation analysis]
article15
1984The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article25
1993Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article0
2000Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics.
[Full Text][Citation analysis]
article73
2001Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article8
1997Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article6
2001Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article0
1994Price Cutting in Liability Insurance Markets. In: The Journal of Business.
[Full Text][Citation analysis]
article19
2000Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business.
[Full Text][Citation analysis]
article6
2002A general model of the impact of absenteeism on employers and employees In: Health Economics.
[Full Text][Citation analysis]
article26
1999Medical negligence and the NHS: an economic analysis In: Health Economics.
[Citation analysis]
article4
1995A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1982Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article1
2007Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics.
[Full Text][Citation analysis]
article3

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated July, 1st 2019. Contact: CitEc Team